Loading: 100%
CHARLES RIVER LABORATORIES INTERNATIONAL INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 11,000 (as per Q2 2017)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker CRLno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17607590105120
datesClosing price (adj.)
13.10.2017112.92
11.10.2017112.80
04.10.2017109.58
27.09.2017107.03
20.09.2017105.80
13.09.2017107.53
06.09.2017107.86
30.08.2017106.80
23.08.2017103.66
16.08.201799.38
09.08.201798.36
02.08.201799.53
26.07.201799.44
19.07.2017100.13
12.07.201799.97
05.07.2017101.23
27.06.201799.90
20.06.201799.10
13.06.201794.14
06.06.201793.07
30.05.201791.79
23.05.201790.62
16.05.201790.19
09.05.201791.70
02.05.201790.36
25.04.201788.36
18.04.201787.69
11.04.201787.59
04.04.201788.10
28.03.201789.36
21.03.201788.12
14.03.201789.50
07.03.201788.12
28.02.201786.97
21.02.201788.40
14.02.201788.95
07.02.201782.58
31.01.201780.80
24.01.201779.28
17.01.201779.79
10.01.201781.30
03.01.201776.53
27.12.201676.04
19.12.201674.96
12.12.201675.06
05.12.201672.14
28.11.201671.56
21.11.201672.44
14.11.201675.06
07.11.201670.29
31.10.201675.88
24.10.201682.82
17.10.201680.05
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
112.92n/a
Market Capitalisation
in million USD
5,374n/a
Enterprise Value
in million USD
6,420n/a
Common Shares Outstanding
as per Jul 28, 2017
47,593,800n/a
Preferred Shares Outstanding
as per Jul 28, 2017
n/a
Average Basic Shares Outstanding
TTM
47,372,750n/a
Average Diluted Shares Outstanding
TTM
48,276,000n/a
Index Membership
n/a
Business Summary
Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2017, million USD, full statements further below)
Profit & Loss
Revenues 1,807n/a
Gross Profit 694n/a
Operating Income 279n/a
EBITDA 0n/a
Net Profit 183n/a
Balance Sheet
Cash and Cash Equivalents 116n/a
Receivables 399n/a
Total Current Assets 738n/a
PP&E 759n/a
Total Assets 2,774n/a
Accounts Payable 65n/a
Current Debt 27n/a
Total Current Liabilities 424n/a
Long-Term Debt 1,116n/a
Total Liabilities 1,792n/a
Total Equity 982n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 38.4%n/a
Operating Margin 15.4%n/a
Net Profit Margin 10.2%n/a
Return on Equity 18.8%n/a
Return on Assets 6.7%n/a
Per Share Figures
Basic EPS 3.87n/a
Diluted EPS 3.79n/a
Sales per Share 38.15n/a
Book Value per Share 20.34n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio 29.21n/a
Price to Sales Ratio 2.96n/a
Price to Book Value 5.45n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales 3.55n/a
Book to Market Value 0.18n/a
Other Ratios
Current Ratio 174.0%n/a
Liabilities to Equity Ratio 182.5%n/a
Debt to Assets Ratio 41.2%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
1,295
1,172
1,133
1,143
1,130
1,166
1,298
1,363
1,681
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-796
-749
-749
-740
-737
-771
-825
-832
-1,035
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
499
423
385
402
392
395
473
531
647
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-251
-253
-257
-220
-226
-244
-295
-325
-409
Selling, General & Administrative
-224
-228
-232
-199
-208
-226
-269
-300
-368
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
-27
-26
-24
-22
-18
-18
-26
-24
-42
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
248
170
128
182
166
151
178
206
237
Non-Operating Income (Loss)
-20
-18
-36
-42
-36
-13
0
-11
-14
Interest Expense, net
-14
-20
-34
-41
-33
-20
-11
-14
-26
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-5
2
-1
0
-3
7
11
3
12
Pretax Income (Loss), Adjusted
229
152
92
140
130
138
178
195
223
Abnormal Gains (Losses)
-700
0
-426
-7
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
-471
152
-334
133
130
138
178
195
223
Income Tax (Expense) Benefit, net
-57
-40
0
-17
-28
-33
-48
-43
-67
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-528
111
-334
116
102
105
130
152
156
Net Extraordinary Gains (Losses)
3
1
-8
-6
-4
-1
-2
-1
0
Discontinued Operations
3
1
-8
-6
-4
-1
-2
-1
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-525
113
-342
110
98
104
128
151
156
Minority Interest
1
2
5
0
-1
-1
-2
-2
-2
Net Income
-525
114
-337
110
97
103
127
149
155
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-525
114
-337
110
97
103
127
149
155
Remarks
restated on Feb 23, 2011 n/a
calculated values,
restated on Feb 27, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 17, 2015 n/a
calculated values,
restated on Feb 12, 2016 n/a
calculated values,
restated on Feb 12, 2016 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
Balance SheetBS data quality: 98% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
183
179
69
110
156
160
118
118
Cash & Cash Equivalents
n/a
183
179
69
110
156
160
118
118
Short Term Investments
n/a
0
0
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
190
193
185
203
221
258
270
364
Accounts Receivable, Net
n/a
190
193
185
203
221
258
270
364
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
103
100
93
88
89
89
94
96
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
120
80
79
84
87
72
77
79
Prepaid Expenses
n/a
0
0
0
0
0
27
30
34
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
8
4
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
112
77
79
84
87
45
47
45
Total Current Assets
n/a
596
553
426
485
553
579
559
657
Property, Plant & Equipment, Net
n/a
864
753
738
717
676
677
678
756
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
745
428
394
384
404
615
551
1,299
Intangible Assets
n/a
154
121
93
85
85
179
0
394
Goodwill
n/a
508
198
198
209
231
321
439
788
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
21
45
45
39
27
42
40
29
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
61
63
59
52
62
73
72
88
Total Noncurrent Assets
n/a
1,608
1,180
1,132
1,101
1,080
1,291
1,228
2,055
Total Assets
n/a
2,204
1,733
1,558
1,586
1,633
1,871
1,788
2,712
Liabilities and owners' equity
Payables & Accruals
n/a
125 125264000
139 138914000
130 130311000
123 123377000
147 146943000
173 172764000
199 199001000
246 246426000
Accounts Payable
n/a
31 31218000
31 30627000
34 34332000
31 31218000
32 31770000
34 33815000
37 36675000
68 68485000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
94 94046000
108 108287000
96 95979000
92 92159000
115 115173000
139 138949000
162 162326000
178 177941000
Short Term Debt
n/a
35 35413000
31 30582000
15 14758000
139 139384000
21 21437000
32 31904000
17 17033000
27 27313000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
89 89096000
90 90284000
72 71728000
79 79486000
79 78654000
90 90018000
96 95727000
156 155854000
Deferred Revenue
n/a
71 71114000
67 66905000
57 56530000
56 56422000
54 54177000
78 78124000
81 81343000
128 127731000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
3 2763000
3 3284000
1 1165000
2 1802000
2 1931000
2 2299000
2 1840000
2 1623000
Miscellaneous Short Term Liabilities
n/a
15 15219000
20 20095000
14 14033000
21 21262000
23 22546000
10 9595000
13 12544000
27 26500000
Total Current Liabilities
n/a
250 249773000
260 259780000
217 216797000
342 342247000
247 247034000
295 294686000
312 311761000
430 429593000
Long Term Debt
n/a
457 457419000
670 670270000
703 703187000
527 527136000
642 642352000
741 740557000
846 845997000
1,208 1207696000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
123 123077000
115 114596000
111 110973000
114 113761000
79 78712000
131 130989000
145 145175000
221 220727000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
23 23087000
48 48223000
56 55717000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
1 1011000
0 0
3 2522000
9 8795000
8 8080000
8 8357000
8 7890000
6 5771000
Miscellaneous Long Term Liabilities
n/a
122 122066000
115 114596000
108 108451000
105 104966000
71 70632000
100 99545000
89 89062000
159 159239000
Total Noncurrent Liabilities
n/a
580 580496000
785 784866000
814 814160000
641 640897000
721 721064000
872 871546000
991 991172000
1,428 1428423000
Total Liabilities
n/a
830 830269000
1,045 1044646000
1,031 1030957000
983 983144000
968 968098000
1,166 1166232000
1,303 1302933000
1,858 1858016000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
2,039 2039226000
1,998 1997649000
2,058 2057706000
2,098 2098112000
2,207 2206980000
2,308 2308485000
2,399 2398815000
2,478 2478234000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-471 -470527000
-769 -768699000
-1,071 -1071120000
-1,136 -1135609000
-1,306 -1305880000
-1,423 -1423260000
-1,541 -1540738000
-1,553 -1553005000
Retained Earnings
n/a
-238 -238493000
-575 -575162000
-466 -465596000
-368 -368301000
-265 -265473000
-139 -138775000
11 10538000
165 165303000
Other Equity
n/a
45 45037000
34 33635000
5 4593000
7 6603000
5 5357000
-74 -74247000
-136 -135548000
-254 -253764000
Equity Before Minority Interest
n/a
1,375 1375243000
687 687423000
526 525583000
601 600805000
641 640984000
672 672203000
733 733067000
837 836768000
Minority Interest
n/a
-1 -1419000
1 1304000
2 1780000
2 2395000
24 23674000
32 32143000
32 32497000
17 17016000
Total Equity
n/a
1,374 1373824000
689 688727000
527 527363000
603 603200000
665 664658000
704 704346000
766 765564000
854 853784000
Total Liabilities & Equity
n/a
2,204 2204093000
1,733 1733373000
1,558 1558320000
1,586 1586344000
1,633 1632756000
1,871 1870578000
2,068 2068497000
2,712 2711800000
Remarks restated on n/a restated on Feb 23, 2011 n/a restated on Feb 27, 2012 n/a restated on Feb 27, 2013 n/a restated on Feb 25, 2014 n/a restated on Feb 17, 2015 n/a restated on Feb 12, 2016 n/a restated on Aug 3, 2016 n/a restated on Aug 9, 2017 n/a
Cash Flow StatementCF data quality: 3% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-525
113
-342
110
98
104
128
151
156
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
87
90
94
85
81
97
96
95
127
Non-Cash Items
750
58
401
45
50
32
30
32
48
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
-33
-44
8
-28
-26
-25
-4
10
-30
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
279
217
160
213
204
208
250
287
301
Change in Fixed Assets & Intangibles
-199
-80
-43
49
-48
-39
-57
-63
-55
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
39
-49
45
56
7
-6
-6
-7
14
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-69
-83
0
0
-17
-29
-234
-248
-648
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
0
3
1
-5
3
0
-1
-2
4
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-229
-209
3
100
-55
-74
-298
-320
-686
Dividends Paid
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
-37
-54
-382
253
-140
-523
-195
-417
-657
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-115
-46
-357
284
-64
-166
-122
-117
-12
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
-115
-46
-357
284
-64
-166
-122
-117
-12
Other Financing Activities
134
19
570
265
93
605
378
539
1,060
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-18
-81
-168
802
-111
-84
61
5
391
Net Cash Before Disc. Operations and FX
32
-73
-5
1,114
38
49
14
-28
5
Change in Cash from Disc. Operations and Other
6
10
4
-2
0
-2
-1
-2
-2
Net Cash Before FX
39
-63
-1
1,113
38
48
13
-30
3
Effect of Foreign Exchange Rates
-17
4
-10
-7
-1
-3
-10
-13
-3
Net Changes in Cash
21
-60
-11
1,106
37
45
2
-43
0
Remarks
restated on Feb 23, 2011 n/a
calculated values,
restated on Feb 27, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 17, 2015 n/a
calculated values,
restated on Feb 12, 2016 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo